The Subscription Arm

In the world of Deus Ex: Human Revolution, the miracle is not the arm. It's the prescription.

Augmentations, the game's artificial limbs and organs, come with a catch. The body rejects them, and the only remedy is an expensive drug called Neuropozyne, taken for as long as you live. Skip it and the machine you were given turns into an injury. The game never lingers on this. It sits in the background of side conversations, a quiet fact of life, and it is easily the most prophetic thing in it.

Eidos Montréal's game came out in August 2011 for Windows, PlayStation 3 and Xbox 360, published by Square Enix. It is a prequel to Ion Storm's Deus Ex (2000) and is set in 2027, twenty-five years before the original. That is next year. We have time to check the work.

The art

Adam Jensen is a security manager at Sarif Industries, a Detroit firm that makes augmentations. Augmented terrorists known as the Tyrants attack the company, Megan Reed and other scientists are presumed dead, and Jensen, gravely wounded, is rebuilt with advanced augmentations. Then he goes looking for who did it. The trail runs through Detroit, Montreal, Hengsha, a fictional Chinese megacity, a Singapore base, and finally the Arctic facility called Panchaea.

What makes it a classic and not just a good shooter is how many roads it leaves open. Almost every space can be taken by stealth, by force or by hacking, and some confrontations can be won by talking. You spend Praxis points to unlock Jensen's upgrades, which turns a character sheet into a debate about what kind of man he is going to be.

It also looks like nothing else. The art team drew on Renaissance painting and the myth of Icarus, and the palette is black and gold: black for the dystopia, gold for hope. It was a marvellous decision in 2011, and the Director's Cut of 2013 still looks like a game that knows what it wants.

The flaws are well known and real. The boss fights were built by a separate studio, Grip Entertainment, and force a shooting gallery on a player who has spent ten hours being clever. The Director's Cut reworked them. The faces are stiff. The conspiracy, with its hidden hands and a final choice among four endings, never reaches the intelligence of the game's central question, which is who owns a body once it contains a product. It would have been braver to let the ending turn on a contract.

It sold 2.18 million copies by November 2011 and scored around 90 on Metacritic.

The prophecy: four claims

The arm. The fantasy is surgical enhancement: limbs and eyes that beat the original. We are not there. The real devices are restorative. In May 2014 the FDA approved the DEKA arm, which reads muscle signals from the upper arm through electrodes and turns them into movement. It's a genuine feat, and a long way from the one Jensen wears. A much-cited 2007 review of the literature found adults rejected body-powered prostheses at about 26% and electric ones at about 23%. People put down hardware that doesn't fit their lives.

The prescription. Here the game was ahead of the news. Second Sight's Argus II retinal implant was approved in the US in 2013, and more than 350 blind people received one. In 2020 the company laid off most of its staff and announced it intended to wind down. IEEE Spectrum reported in 2022 that users had a device in their heads with no one to maintain it. One recipient, Ross Doerr, called it "fantastic technology and a lousy company." No rejection drug was involved, but the logic was Neuropozyne's: your body depends on a firm's solvency. A contract that depends on one firm's solvency is not one anyone should sign for an eye.

The implant in the skull. Jensen's augmentations include direct interfaces with his nervous system. In January 2024 Neuralink implanted its first human patient, Noland Arbaugh, who is paralysed from the shoulders down. In March a livestream showed him moving a cursor and playing online chess with his mind. About a month after surgery, some of the implant's threads retracted from his brain, reducing his control. Neuralink said software changes improved performance. By August 2025 he was reportedly using the device about ten hours a day. It is a real thing, in a trial, for people who have lost something. It isn't yet a luxury upgrade, and the game's rich citizens can't buy it.

The newsreader. Eliza Cassan, the public face of Picus Communications, is a polished broadcaster who turns out to be artificial. In November 2018 China's Xinhua agency unveiled two virtual news anchors, built with Sogou, which could read text round the clock; Xinhua admitted they weren't true AI. In October 2025 Channel 4's Dispatches ran a documentary fronted by a fully AI-generated presenter, revealed near the end. The game made this a twist. We made it a stunt.

The reading

The surprise of replaying it is how little of the future depends on the hardware. The cyborg parts are the easy ones, and a lot of them are already underway in clinics. The harder part is the arrangement. The most advanced technology in the world sat in a body that someone else could switch off, and the game understood that long before regulators did.

That is also the argument for what Nearfi calls ARRIVING. Not the biceps; the terms. A better 2027 would be one where the repair, the data and the upgrade belong to the person wearing them. The game doesn't tell you how to get there. It does make you feel the missing clause.

Play it before the year it's named for. Then read the small print on anything that attaches to you.